Lv1
20 积分 2025-08-15 加入
Clinical progress of engineered cellular immunotherapies for autoimmunity
10天前
已完结
BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial
10天前
已完结
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
1个月前
已完结
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2个月前
已完结
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2个月前
已关闭
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2个月前
已关闭
Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index
3个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
6个月前
已完结
Ulcerative colitis
6个月前
已完结
皖公网安备34019202002308
